2010
Antibiotic resistence changes in infection following transrectal ultrasound guided prostate biopsy - review of 5 years period
ČERMÁK, Aleš, Natália MAREČKOVÁ, Kamila KARMAŠOVÁ a Dalibor PACÍKZákladní údaje
Originální název
Antibiotic resistence changes in infection following transrectal ultrasound guided prostate biopsy - review of 5 years period
Název anglicky
Antibiotic resistence changes in infection following transrectal ultrasound guided prostate biopsy - review of 5 years period
Autoři
ČERMÁK, Aleš (203 Česká republika, garant, domácí), Natália MAREČKOVÁ (703 Slovensko, domácí), Kamila KARMAŠOVÁ (203 Česká republika, domácí) a Dalibor PACÍK (203 Česká republika, domácí)
Vydání
European Urology Supplements, Elsevier B.V. 2010, 1569-9056
Další údaje
Jazyk
čeština
Typ výsledku
Článek v odborném periodiku
Obor
30000 3. Medical and Health Sciences
Stát vydavatele
Česká republika
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 2.139
Kód RIV
RIV/00216224:14110/10:00046964
Organizační jednotka
Lékařská fakulta
Klíčová slova anglicky
prostate cancer infectious complications antibiotic therapy antibiotic resistence
Změněno: 19. 1. 2011 21:54, MUDr. Vítězslav Vít
V originále
The authors did not observe an increase in the incidence of infectious complications following PB in past five years. Our standard antibiotic prophylaxis with fluorochinolone + metronidazol has proved to be still effective in more than 97% of PBs.On the other hand, in cases of failed prophylaxis, we noticed a substantial increase in the antibiotic resistance to the commonly used antibiotics. This should lead us to an aggressive treatment and early administration of wide spectrum antibiotics in patients suffering serious septic complications (meropenem,ceftazidime, tazobactam + ticarcilin).
Anglicky
The authors did not observe an increase in the incidence of infectious complications following PB in past five years. Our standard antibiotic prophylaxis with fluorochinolone + metronidazol has proved to be still effective in more than 97% of PBs.On the other hand, in cases of failed prophylaxis, we noticed a substantial increase in the antibiotic resistance to the commonly used antibiotics. This should lead us to an aggressive treatment and early administration of wide spectrum antibiotics in patients suffering serious septic complications (meropenem,ceftazidime, tazobactam + ticarcilin).